The SWITCH trial, comparing hydroxyurea with phlebotomy to standard therapy with blood transfusions and deferasirox, was halted when the former new combination failed to offer additional benefit. Medscape Medical News (Source: Medscape Today Headlines)
phlebotomy training ma phlebotomy courses phlebotomy training denver
No comments:
Post a Comment